Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “18F-PSMA”

98 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 98 results

Large-scale testing (Phase 3)Looking for participantsNCT04794777
What this trial is testing

Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer

Who this might be right for
Prostate Cancer
Stefan Carlsson 450
Early research (Phase 1)Study completedNCT03497377
What this trial is testing

Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.

Who this might be right for
Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Early research (Phase 1)Looking for participantsNCT06062745
What this trial is testing

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

Who this might be right for
Advanced Prostate CancerMetastatic Prostate CancerMetastatic Prostate Neuroendocrine Carcinoma
Brigham and Women's Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT05939414
What this trial is testing

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Who this might be right for
Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals 450
Testing effectiveness (Phase 2)Looking for participantsNCT07455903
What this trial is testing

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Who this might be right for
Prostate CancerLocalized Prostate Carcinoma
Baptist Health South Florida 50
Not applicableUnknownNCT04521894
What this trial is testing

The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer

Who this might be right for
Prostatic Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 500
Not applicableNot Yet RecruitingNCT06298838
What this trial is testing

High-resolution Intra-operative PSMA PET-CT in Prostate Cancer

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 10
Testing effectiveness (Phase 2)Study completedNCT01815515
What this trial is testing

Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Testing effectiveness (Phase 2)Looking for participantsNCT05413850
What this trial is testing

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancermCRPC+3 more
Blue Earth Therapeutics Ltd 82
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07635524
What this trial is testing

Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT.

Who this might be right for
Prostate Cancer
Hoag Memorial Hospital Presbyterian 34
Not applicableStudy completedNCT02687139
What this trial is testing

Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaKidney Cancer
Johns Hopkins University 34
Testing effectiveness (Phase 2)Looking for participantsNCT06865768
What this trial is testing

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique

Who this might be right for
Prostate Carcinoma
Emory University 90
Very early researchLooking for participantsNCT03861676
What this trial is testing

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableStudy completedNCT06919159
What this trial is testing

Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)Prostate-specific Membrane AntigenPositron Emission Tomography (PET)
Jiequn Yu 45
Not applicableLooking for participantsNCT06820333
What this trial is testing

Impact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Heinrich-Heine University, Duesseldorf 200
Early research (Phase 1)Study completedNCT01417182
What this trial is testing

Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Very early researchStudy completedNCT03232164
What this trial is testing

PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer

Who this might be right for
Prostate CancerProstate Neoplasm
University of Wisconsin, Madison 126
Not applicableLooking for participantsNCT06363435
What this trial is testing

AI-based Measurements of Tumour Burden in PSMA PET-CT

Who this might be right for
Prostate Cancer
Elin Tragardh 1,500
Testing effectiveness (Phase 2)Looking for participantsNCT07393867
What this trial is testing

Androgen-responsive POSLUMA-guided Intra-prostatic Boost

Who this might be right for
Intermediate Risk Prostate CancerHigh Risk Prostate CancerProstate Cancer
Martin T. King, MD, PhD 23
Large-scale testing (Phase 3)UnknownNCT05622162
What this trial is testing

Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7

Who this might be right for
Prostate Cancer18F- FluorocholinePSMA PET+3 more
ITEL Telecomunicazioni Srl 106
Next Page